Skip to main content

Table 4 Adverse events

From: Combination use of platelets and recombinant activated factor VII for increased hemostasis during acute type a dissection operations

Complication Control (n = 46) rFVII + platelet (n = 25) pValue
Reoperation for bleeding 1(2.2%) 0 0.648
Delayed sternal closure 0 0 1
Sternal infection 0 0 1
Postoperative arrhythmia 3(6.5%) 2(8%) 0.581
Acute renal failure 2(4.3%) 1(4%) 0.718
Myocardial infarction 0 0 1
Pulmonary embolism 0 0 1
Mesenteric ischemia 0 0 1
Any stroke 1(2.2%) 1(4%) 0.584
Embolic stroke 0 0 1
Permanent paraparesis 1(2.2%) 0 0.648
Over 7 days stay in ICU 5(10.9%) 2(8%) 0.526
30-day/in-hospital death 2(4.3%) 1(4%) 0.718
  1. Values are expressed as number (percent).